VanholderR.C., RingoirS.M.. Adequacy of dialysis: A critical analysis.Kidney Int1992; 42: 540–58.
2.
HakimR.. Assessing the adequacy of dialysis.Kidney Int1990; 37: 822–32.
3.
LowrieE.G., LairdN.M., ParkerT.F., SargentJ.A.. Effect of the hemodialysis prescription on patient morbidity. Report from the National Cooperative Dialysis Study.N Engl J Med1981; 305: 1176–81.
GotchF.A., KruegerK.K.., (eds) Adequacy of dialysis.Kidney Int1975; 7(suppl 2): S1–263.
6.
DepnerT.A.. Assessing adequacy of hemodialysis: Urea modeling.Kidney Int1994; 45: 1522–35.
7.
OwenW.F., LewN.L., LuiY., LowrieE.G., LazarusJ.M.. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis.N Engl J Med1993; 329: 1001–6.
8.
DepnerT.A.. Pitfalls in quantitating hemodialysis.Semin Dial1993; 6: 127–33.
9.
LairdN.M., BerkeyC.S., LowrieE.G.. Modeling success or failure of dialysis therapy: the National Cooperative Dialysis Study.Kidney Int1983; 23(suppl 13): S101–S106.
TeschanP.E., GinnH.E., BourneJ.R.. Quantitative indices of clinical uremia.Kidney Int1979; 15: 676–97.
12.
BourneJ.R., TeschanP.E.. Computer methods, uremic encephalopathy and adequacy of dialysis.Kidney Int1983; 24: 496–506.
13.
LewisE.G., O'NeillW.M., DustmanR.E., BeckE.C.. Temporal effects of hemodialysis on measures of neural efficiency.Kidney Int1980; 17: 357–63.
14.
GilliP., De BastianiP.. Cognitive function and regular dialysis treatment.Clin Nephrol1983; 19: 188–92.
15.
MarshJ.T., BrownW.S., WolcottD., LaudsverkJ., NiessensonR.. Electrophysiological indices of CNS function in hemodialysis and CAPD.Kidney Int1986; 30: 957–63.
16.
LindsayR.M., HendersonL.W.. Adequacy of dialysis.Kidney Int1988; 33(suppl 24): S92–9.
17.
BlakeP.G., SombolosK., AbrahamG.. Lack of correlation between urea kinetic indices and clinical outcome in CAPD patients.Kidney Int1991; 39: 700–6.
18.
FuerstP., ZimmermanL., BergstroemJ.. Determination of endogenous middle molecules in normal and uremic body fluids.Clin Nephrol1976; 5: 178–87.
19.
LukeR.G.. Uremia and the BUN.N Engl J Med1981; 305: 1213–5.
20.
SchootsA., MikkersF., CramersC., de SmetR., RingoirsS.. Uremic toxins and the elusive middle molecules.Nephron1984; 38: 1–8.
21.
RitzE., DeppischR., NawrothP.. Toxicity of ureamia - does it come of AGE?Nephrol Dial Transplant1994; 9: 1–2.
22.
HoerlW.H., HeidlandA.. Evidence for the participation of granulocyte proteinases on intradialytic catabolism.Clin Nephrol1984; 21: 314–22.
23.
ParkerT.F., HusniL., HuangW., LewN., LowrieE.G.. and Dallas Nephrology Associates. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis.Am J Kid Dis1994; 23: 670–80.
24.
CollinsA.J., MaJ.M., UmenA., KeshaviahP.. Urea index and other predictors of hemodialysis patient survival.Am J Kid Dis1994; 23: 272–82.
25.
HakimR., BreyerJ., IsmailN., SchulmanG.. Effects of dose of dialysis on morbidity and mortality.Am J Kid Dis1994; 23: 661–9.
26.
LinsayR., HeidenheimA.P., SpannerE., KortasC., BlakeP.G.. Adequacy of hemodialysis and nutrition - important determinants of morbidity and mortality.Kidney Int1994; 45: S85–91.
27.
RoncoC., BurchardiH.. Management of acute renal failure in the critically ill patient. In: PinskyM.R., DhainautJ.F.A., eds. Pathophysiobiologic Foundations of Critical Care.Williams and Wilkins Baltimore1993.
28.
SwartzR.D., ValkT.W., BrainA.J.P., HsuC.H.. Complications of hemodialysis and peritoneal dialysis in acute renal failure.Trans Am Soc Artif Intern Organs19803: 98–101.
KjellstrandC.M., RosaA.A., ShidemannJ.R.. Hypotension during hemodialysis: osmolatity fall is an important pathogenic factor.Trans Am Soc Artif Intern Organs1980; 3: 11–4.
32.
JohnsonN.R., BischelM.D., BoylenC.T., MohlerJ.G.. Hypoxemia and hyperventilation in chronic hemodialysis.Clin Res1970; 19: 145–9.
33.
BischelM.D., ScolesB.G., MohlerJ.G.. Evidence for pulmonary microembolization during hemodialysis.Chest1975; 67: 335–7.
34.
BischelM.D., OrrellF.L., ScolesB.G., MohlerJ.G., BarbourB.H.. Effects of microemboli blood filtration during hemodialysis.Trans Am Soc Artif Intern Organs1973; 19: 492–7.
35.
KaplowL.S., FoffinetJ.A.. Profound neutropenia during the early phase of hemodialysis.JAMA1968; 203: 1135–7.
36.
ChenowethD.E., CheungA.K., HendersonL.W.. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.Kidney Int1983; 24: 764–9.
37.
HakimR.M., LowrieE.G.. Hemodialysis associated neutropenia hypoxemia: the effect of dialyzer membrane materials.Nephron1982; 32: 32–9.
38.
MaultJ.R., DechertR.E., BartlettR.H., SwartzR.D., FergusonS.K.. Oxygen consumption during hemodialysis for acute renal failure.Trans Am Soc Artif Intern Organs1982; 28: 510–3.
39.
CarlonG.C., CampfieldP.B., GoldinerP.L., TurnbullA.D.. Hypoxemia during hemodialysis.Crit Care Med1979; 7: 497–501.
40.
EndouK., KamijimaJ., KakubariY., KirkawadaR.. Hemodynamic changes during dialysis.Cardiology1978; 63: 175–87.
41.
Von HartizchB., EatonJ.W., BuselmeierT.J., KjellstrandC.M.. Dialysis disequilibrium: a manifestation of impaired tissue oxygenation.Trans Am Soc Artif Intern Organs1974; 20: 373–7.
42.
MannsM., SiglerM.H., TeehanB.P., FreesR., DixitK.. Effects of intermittent hemodialysis on residual renal function in critically ill patients with acute renal failure.(Abstract) Int J Artif Organs1994; 17: 442.
43.
DieberL., KozolR., WilsonR.F., MahajanS., Abu-HamdanD., ThomasD.. Gastric intramucosal acidosis in patients with chronic kidney failure.Surgery1993; 113: 520–6.
44.
SmitJ.C., Gareth JonesJ.. Oxygen saturation during hemodialysis. Ren.Fail1993; 15: 239–45.
45.
CraddockP.R., FehrJ., BrighamK.L., KronenbergR.S., JacobH.S.. Complement and leukocyte-mediated pulmonary dysfunction in haemodialysis.N Engl J Med1977; 296: 769–74.
46.
AunsholtN.A., LarsenC.. The arterial oxygen extraction tension and oxygen compensation factor during acetate and bicarbonate dialysis.Blood Purif10: 1992; 317–25.
47.
BouffardY., VialeJ-P, AnnatG.. Pulmonary gas exchange during hemodialysis.Kidney Int1986; 30: 920–3.
48.
RomaldiniH., Rodriguez-RoisinR., LopezF.A., ZieglerT.W., BencowitzH.Z., WagnerP.D.. The mechanisms of arterial hypoxemia during hemodialysis.Am Rev Respir Dis1984; 129: 780–4.
49.
PattersonR.W., NissensonA.R., MillerJ., SmithR.T., NarinsR.G., SullivanS.F.. Hypoxemia and pulmonary gas exchange during hemodialysis.J Appl Physiol1981; 50: 259–64.
GutierrezA., AlvestrandA., WahrenJ., BergstromJ.. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans.Kidney Int1990; 38: 487–94.
52.
LugerA., KovarikJ., StummvollH-K, UrbanskaA., LugerT.A.. Blood-membrane interaction in hemodialysis leads to increased cytokine production.Kidney Int1987; 32: 84–8.
53.
LienJ., ChanV.. Risk factors influencing survival in acute renal failure treated by hemodialysis.Arch Intern Med1985; 145: 2067–9.
54.
GroeneveldA.B.J., TranD.D., van der MeulenJ., NautaJ.J.P., ThijsJ.G.. Acute renal failure in the medical intensive care unit: predisposing, complicating factors and outcome.Nephron1991; 59: 602–10.
LangeH.W., AeppliD.M., BrownD.C.. Survival of patients with acute renal failure requiring dialysis after open heart surgery: early prognostic indicators.Am Heart J1987; 113: 1138–43.
57.
SpiegelD.M., UllianM.E., ZerbeG.O., BerlT.. Determinants of survival and recovery in acute renal failure patients dialysed in intensive care unit.Am J Nephrol1991; 11: 44–7.
58.
ChewS.L., LinsR.L., DaelemansR., De BoerM.E.. Outcome in acute renal failure.Nephrol Dial Transplant1993; 8: 101–7.
59.
KramerP., WiggerW., RiegerJ., MatthaeiD., SchelerF.. Arteriovenous hemofiltration: a new and simple method for treatment of overhydrated patients resistant to diuretics.Klin Wochenschr1977; 55: 1121–2.
60.
GeronemusR., SchneiderN.. Continuous arteriovenous hemodialysis: a new modality for treatment of acute renal failure.Trans Am Soc Artif Intern Organs1984; 30: 610–3.
61.
BellomoR., ParkinG., LoveJ., BoyceN.. Management of acute renal failure in the critically ill with continuous venovenous hemodiafiltration.Ren Fail1992; 14: 183–6.
62.
WendonJ., SmithiesM., SheppardA., Bullenk TinkerJ., BihariD.. Continuous high-volume veno-venous hemofiltration in acute renal failure.Intensive Care Med1989; 15: 358–63.
63.
Mc DonaldB.R., MehtaR.L.. Decreased mortality in patients with acute renal failure undergoing continuous arteriovenous hemodialysis.Contrib Nephrol1991; 93: 51–6.
64.
HakimR.M.. Clinical implications of hemodialysis membrane biocompatibiliy.Kidney Int1993; 44: 484–94.
KnausW.A., DraperE.A., WagnerD.P., ZimmermanJ.E.. APACHE II: A severity of disease classification system.Crit Care Med1985; 13: 818–29.
67.
KnausW.A., WagnerD.A., DraperE.A.. The APACHE III Prognostic system. Risk predictions of hospital mortality for critically ill hospitalized adults.Chest1991; 100: 1619–36.
68.
Le GallJ-R, LemeshowS., SaulnierF.. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter Study.JAMA1993; 270: 2957–63.
69.
LemeshawS., TeresD., KlarJ., Spitz AvruninJ., GehlbachS.H., RapoportJ.. Mortality probability models (MPM II) based on an international cohort of Intensive Care Unit patients.JAMA1993; 270: 2478–86.
70.
The ACCP/SCCM Consensus Conference Committee.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Chest1992; 101: 1644–55.
71.
Europeen Society of Intensive Care Medicine Expert Panel,. The use of the pulmonary artery catheter.Intensive Care Med1991; 17: l–VIII.
SlutskyA.S.. Consensus conferencence on mechanical ventilation. Part I.Intensive Care Med1994; 20: 64–79.
74.
SlutskyA.S.. Consensus conference on mechanical ventilation. Part II.Intensive Care Med1994; 20: 150–62.
75.
GattinoniL., FerianiM.. Acid-base derangements in acute renal failure. In: PinskyM.R., DhainautJ-FA, eds. Pathophysiologic Foundations of Critical Care.Williams & Wilkins, Baltimore1993.
76.
KveimM., NesbakkenR.. Utilization of exogenous acetate during hemodialysis.Trans Am Soc Artif Int Organs1975; 21: 138–42.
77.
BouffardY., VialeJ.P., AnnatG.. Pulmonary gas exchange during hemodialysis.Kidney Int1986; 30: 920–7.
78.
OhM.S., UribarriJ., Del MonteM.L., FriedmanE.A., CarrollH.J.. Consumption of CO2 in metabolism of acetate as an explanation for hypoventilation and hypoxemia during hemodialysis.Proc Clin Dial Transpl Forum1970; 9: 226–31.
79.
KirschbaumB., GalishoffM., ReinesH.D.. Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagulation.Crit Care Med1993; 20: 349–53.
80.
BartonI.K., StreatherC.P., HiltonP.J., BradleyR.D.. Successful treatment of severe lactic acidosis by haemofiltration using a bicarbonate-based replacement fluid.Nephrol Dial Transplant1991; 6: 368–70.
81.
DavenportA., WillE.J., DavisonA.M.. Paradoxical increase in arterial hydrogen ion concentration in patients with hepatorenal failure given lactate-based fluids.Nephrol Dial Transplant1990; 5: 342–6.
82.
NimmoG., GrantI.S., MackenzieS.J.. Lactate and acid base changes in the critically ill.Postgrad Med J Suppl1991; 1: S56–61.
83.
NimmoG.R., MackenzieS.J., WalkerS., NicolM., GrantI.S.. Acid-base response to high volume haemofiltration in the critically ill.Nephrol Dial Transplant1993; 8: 8: 854–7.
84.
BocciV.. Interleukins: Clinical Pharmacokinetics and practical implications.Clin Pharmacokinet1991; 21: 274–84.
85.
PessinaG.P., PaciniA., BocciV., MaioliE., NaldiniA.. Studies on tumor necrosis factor (TNF): II Metabolic fate and distribution of human recombinant TNF.Lymphokine Res1987; 6: 35–43.
86.
KlapprothJ., CastellJ., GeighT., AndausT., HeinrichP.C.. Fate and biological action of human recombinant interleukin I beta in the rat in vivo.Eur J Immunol1989; 19: 1485–90.
87.
HowdieshellT.R., BlalockW.E., BowenP.A., HawkinsM.L., HessC.. Management of post-traumatic acute renal failure with peritoneal dialysis.Am Surg1992; 58: 378–82.
PattisonM.L., LeeS.M., OgdenD.A.. Continuous arteriovenous hemodiafiltration: an aggressive approach to the management of acute renal failure.Am J Kid Dis1988; 11: 43–7.
90.
VoermanH.J., Strack van SchijndelR.J.M., ThijsL.G.. Continuous arteriovenous hemodiafiltration in critically ill patients.Crit Care Med1994; 18: 911–4.
91.
ReynoldsH.N., BorgU., BelzbergH., WilesC.E.. Efficacy of continuous arteriovenous hemofiltration with dialysis in patients with renal failure.Crit Care Med1991; 19: 1387–94.
BellomoR., ErnestD., LoveJ., ParkinG., BoyceN.. Continuous arteriovenous hemodiafiltration: an optimal therapy for acute renal failure in an intensive care setting.Aust NZ J Med1990; 20: 237–42.
94.
BellomoR., ParkinG., LoveJ., BoyceN.. Management of acute renal failure in the critically ill with continuous veno-venous hemodiafiltration.Ren Fail1992; 14: 183–6.
95.
SchaeferG.E., DolringC., SodemannK., RussA., SchroederH.M.. Continuous arteriovenous and venovenous hemodialysis in critically ill patients.Contrib Nephrol1991; 93: 23–8.
96.
HumphreyH., HallJ., SznajderI.. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure.Chest1990; 97: 1176–80.
97.
RoncoC., FerianiM., ChiaramonteS.. Impact of high blood flows on vascular stability in hemodialysis.Nephrol Dial Transpl1990: Suppl 5, 1: 109–14.
98.
KjellstrandC., UlanR., Odar-CederlofI., EricssonF., SkroderR., JacobsonS.. All derived Kt/V overestimate and increasingly deviate from the true Kt/V as dialysis speed is increased and dialysis time shortened.J Am Soc Nephrol1991; 2: 332–7.
99.
SargentJ.A.. Shortfalls in the delivery of dialysis.Am J Kidney Dis1990; 15: 500–10.
100.
GotchF.A., YarianS., KeenM.. A kinetic survey of US hemodialysis prescriptions.Am J Kidney Dis1990; 15: 511–5.
101.
Le FebreJ.M., SpannerE., HeidenheimA.L., LindsyR.M.. kt/V patients do not get what the physician prescribes.ASAIO Trans1991; 37: M132–3.
102.
DelmezJ.A., WindusD.W.. The St. Louis Nephrology Study Group. Hemodialysis prescription and delivery in a metropolitan community.Kidney Int1992; 41: 1023–8.
103.
DepnerT., RizwanS., CheerA., WagnerJ.. Peripheral urea disequilibrium during hemodialysis is temperature-dependent.J Am Soc Nephrol1991; 2: 321–5.
RoncoC., ConzP., BoschJ.P., LewS., La GrecaG.. Assesment of adequacy in peritoneal dialysis.Advances in Renal Replacement Therapy1994; 1: 15–23.
106.
RoncoC., ConzP., AgostiniF., BoschJ.P., LewS., La GrecaG.. The concept of adequacy in peritoneal dialysis.Perit Dial Intern1994; 14(suppl 3): S93–8.
107.
RoncoC., BoschJ.P., LewS.. Adequacy of continuous ambulatory peritoneal dialysis. Comparison with other dialysis techniques.Kidney Int (in press).
108.
DepnerT.A., RizwanS., CheerA.Y., WagnerJ., EderL.A.. High venous urea concentration in the opposite arm: a consequence of hemodialysis-induced compartment disequilibruim.J Am Soc Artif Intern Organs1991; 37: 141–3.
ClarkW.R., MuellerB.A., AlakaK.J., MaciasW.L.. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure.J Am Soc Nephrol1994; 4: 1413–20.
111.
KeshaviahP., NolphK., Van StoneJ.. The peak concentration hypothesis: a urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis.Perit Dial Int1989; 9: 257–60.
112.
FrankenfieldD.C., ReynoldsH.N., WilesC.E., BadellinoM.M., SiegelJ.N.. Urea removal during continuous nemo-filtration.Crit Care Med1994; 22: 407–12.
113.
BellomoR., MartinH., ParkinG., LoveJ., KeazleyY., BoyceN.. Continuous arteriovenous haemodiafiltration in the critically ill: influence on major nutrient balances.Intensive Care Med1991; 17: 399–402.
114.
BellomoR., SeacombeJ., DaskalakisM.. A prospective comparative study of moderate versus high protein intake for critically ill patients with acute renal failure.Proc Aust NZ Intens Care Society, Scientific meeting (Sydney) (Abstract) 1994; 91.
115.
BellomoR., MansfieldD., RumbleS., ShapiroJ., ParkinG., BoyceN.. A comparison of conventional dialytic therapy and acute continuous hemodiafiltration in the management of acute renal failure in the critically ill.Ren Fail1993; 15: 595–602.
RosaA.A., ShidemanJ., KjellstrandC.M.. Dialysis symptoms and stabilization in long-term dialysis, practical application of the CUSUM plot.Arch Intern Med1980; 140: 804–10.
118.
NiesA.S., RobertsonD., StoneW.J.. Hemodialysis hypotension is not the result of uremic peripheral autonomic neuropathy.J Lab Clin Med1979; 94: 395–401.
119.
KjellstrandC.M., RosaA.A., ShidemanJ.R.. Hypotension during dialysis: osmolality fall is an important pathogenetic factor.ASAIO J1980; 3: 11–8.
120.
HakimR., WingardR.L., ParkerR.A.. Effect of the dialysis membrane in the treatment of patients with acute renal failure.N Engl J Med1994; 331: 1338–42.
121.
OgdenD.A.A.. A double blind crossover comparison of high and low sodium dialysis.Proc Clin Dial Transplant Forum1978; 8: 157–61.
122.
LeskiM., NiethammerT., WyssT.. Glucose enriched dialysate and tolerance to maintenance hemodialysis.Nephron1979; 24: 271–6.
123.
LauerA., SaccaggiA., RoncoC., BelledonneM., GladmanS., BoschJ.. Continuous arteriovenous hemofiltration in the critically ill patient.Ann Intern Med1983; 99: 455–60.
124.
CanaudB., CristolJ.P., KloucheK.. Slow continuous ultrafiltration: a means of unmasking myocardial functional reserve in end-stage cardiac disease.Contrib Nephrol1991; 93: 79–85.
125.
KrugerI., JacobiC., LandwehrP.. Effects of continuous venovenous hemofiltration on pulmonary function and hemodynamics in postoperative septic multiorgan failure.Contrib Nephrol1995; 116: 108–11.
126.
KellerE., Reetze-BonordenP., LuckingH.P., BöhlerJ., SchollmeyerP.. Continuous arteriovenous hemodialysis: experience in twenty-six intensive care patients.Contrib Nephrol1991; 93: 47–50.
127.
LaggnerA.N., DrumlW., LenzK., SchneeweissB., GrimmG.. Influence of ultrafiltration/hemofiltration on extravascular lung water.Contrib Nephrol1991; 93: 65–70.
128.
AlarabiA.A., WikstromB., DanielsonB.G.. Continuous arteriovenous hemodialysis and hemofiltration in acute renal failure: comparison of uremic control.Contrib Nephrol1991; 93: 61–4.
129.
BandouinS.V., WigginsJ., KeoghB.F., MorganC.J., EvansT.. Continuous veno-venous haemofiltration following cardio-pulmonary bypass.Intensive Care Med1993; 19: 290–3.
130.
CoraimF.J., CoraimH.P., EbermannR., StellwagF.M.. Acute respiratory failure after cardiac surgery: clinical experience with the application of continuous arteriovenous hemofiltration.Crit Care Med1986; 14: 714–8.
131.
HenrichW.L.. Arteriovenous or venovenous continuous therapies are not surperior to standard hemodialysis in all patients with acute renal failure.Seminars Dial1993; 6: 174–6.
132.
HenrichW.L., WoodardT.D., Mc PaulJ.J.. The chronic efficacy and safety of high dialysate: double crossover study.Am J Kidney Dis1982; 2: 349–53.
133.
VelezR.L., WoodardT.D., HenrichW.L.. Acetate and bicarbonate hemodialysis in patients with and without autonomic dysfunction.Kidney Int1984; 26: 59–65.
134.
ShermanR.A., RubinM.P., CoolyR.P., EisingerR.P.. Amelioration of hemodialysis-associated hypotension by the use of cool dialysate.Am J Kidney Dis1985; 5: 124–7.
135.
AgarwalR., JostC., Khair-el-dinT., VictorR., GrayburnP., HenrichW.L.. 35° C dialysis increases peripheral resistance and improves hemodynamic stability in patients.J Am Soc Nephrol1992; 3: 351.
136.
SchulmanG., FogoA., GungA., BadrK., HakimR.. Complement activation retards resolution of acute ischemic renal failure in the rat.Kidney Int1991; 40: 1069–74.
137.
HakimR., WingardR.L., LawrenceP., ParkerA., SchulmanG.. Use of biocompatible membranes improves outcome and recovery from acute renal failure.J Am Soc Nephrol1992; 3: 367.
138.
HakimR.. Clinical implications of hemodialysis membranes biocompatibility.Kidney Int1993; 44: 484–94.
GuitierrezA., AlvestrandA., WahrenJ., BergstromJ.. Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans.Kidney Int1990; 38: 487–94.
141.
BouffardY., VialeJ.P., AnnatG., DelafosseB., GuillanneG., MotinJ.. Energy expenditure in the acute renal failure patient mechanically ventilated.Intensive Care Med1987; 13: 401–4.
142.
ElwynD.H.. Nutritional requirements of stressed patients. Text book of critical care2nd edition. (Shoemaker, et al eds) WB Saunders, Phillidelphia1989.
143.
CerraF.B.. Hypermetabolism, organ failure and metabolic support.Surgery1987; 101: 1–6.
144.
JeejeebhoyK.N.. Nutrition in critical illness. In: CivettaJ.M., TaylorR.W., KirbyR.R., eds. Crit Care, 2nd ed.JB Lippinott Co.Philadelphia1992; 1093–117.
145.
BergerR., AdamsL.. Nutritional support in the critical care setting.Chest1989; 96: 139–50.
146.
DalyJ.M., ReynoldJ., SigalR.K., ShouJ., LibermanM.D.. Effects of dietary protein and amino acids on immune function.Crit Care Med1990; 18: S86–93.
147.
DeitchE.A., DazhongX., QiL., SpecianR.D., BergR.D.. Protein malnutrition alone and in combination with endotoxin impairs systemic and gut-associated immunity.JPEN1992; 16: 25–31.
148.
TobackF.G., DaddR.C., MaierE.R., HavenerL.J.. Amino acid administration enhances renal protein metabolism after acute tubular necrosis.Nephron1983; 33: 238–43.
149.
Garza-QuinteroR., Ortega-LopezJ., SteinJ.H., van KatachalamM.A.. Alanine protects rabbit proximal tubules against anoxic injury in vitro.Am J Physiol1987; 258: F1075–83.
150.
KierdorfH., KindlerJ., SieberthH.G.. Nitrogen balance in patients with acute renal failure treated by continuous haemofiltration.Nephrol Dial Transplant1986; 1: 72–7.
151.
KierdorfH.. Continuous versus intermittent treatment: clinical results in acute renal failure.Contrib Nephrol1991; 93: 1–12.
152.
WeissmanC., HeymanAl. Nutritional care of the critically ill patient with respiratory failure.Crit Care Clin1987; 3: 185–203.
153.
PingletonS.K., HarmonG.S.. Nutritional management in acute respiratory failure.JAMA1987; 257: 3094–9.
154.
TobackF.G.. Amino acid enhancement of renal regeneration after acute tubular necrosis.Kidney Int1977; 12: 193–8.
155.
La GrecaG., BiasioliS., ChiaramonteS.. Studies on brain density in hemodialysis and peritoneal dialysis.Nephron1982; 31: 146–50.
156.
La GrecaG., DettoriP., BiasioliS.. Brain density studies during dialysis.Lancet1980; 2: 582.
157.
WinneyR.J., KeanD.M., BestJ.J.K., SmithM.A.. Changes in brain water with haemodialysis.Lancet1986; 2: 1107–8.
158.
KishimotoT., YamagamiS., TanakaH.. Superiority of haemofiltration to haemodialysis for treatment of chronic renal failure: Comparative studies between haemofiltration and haemodialysis on dialysis disequilibrium syndrome.J Artif Organs1980; 4: 86–93.
159.
DavenportA., WillE.J., DavisonA.M.. Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure.Kidney Int1993; 43(suppl 41): S245–51.
160.
DavenportA., WillE.J., DavisonA.M.. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure.Crit Care Med1993; 21: 328–38.
161.
DavenportA., WillE.J., DavisonA.M.. Changes in intracranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy.Nephron1989; 53: 142–6.
162.
DavenportA., WillE.J., DavisonA.M.. Changes in intracranial pressure during machine and continuous haemofiltration.Int J Artif Organs1989; 12: 439–44.
163.
DavenportA., FinnR., GoldsmithH.J.. Management of patients with renal failure complicated by cerebral oedema.Blood Purif1989; 7: 203–9.
164.
ArieffAl. Dialysis disequilibrium syndrome: Current concepts on pathogenesis and prevention.Kidney Int1994; 45: 629–35.
165.
MatsubaraS., OkabeK., OuchiK.. Continuous removal of middle molecules by hemofiltration in patients with acute liver failure.Crit Care Med1990; 18: 1331–6.
166.
AyresS.M.. SCCM's New Horizons Conference on sepsis and septic shock.Crit Care Med1985; 13: 864–6.
167.
BalkR.A., BoneR.C.. The septic syndrome: definitions and clinical implication.Crit Care Clin1989; 5: 1–8.
168.
FisherC.J., OpalS.M., DhainautJ-F. and the CB 0006 Sepsis Syndrome Study Group. Influence of an antitumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis.Crit Care Med1993; 21: 318–27.
169.
MarshallJ.C.. Infection and the host septic response: implications for clinical trials of mediator antagonism. In: VincentJ-L, ed. 1994 Yearbook of Intensive Care and Emergency Medicine.Springer, Heidelberg1994; 3–13.
170.
GrazianiG., BadalamentiS., BordoneG.. The renal removal of cytokines in sepsis.Preliminary report. Proc 3rd Int Satel Symposium on ARF, Halkidiki 1993; 660.
171.
BellomoR., TippingP., BoyceN.. Continuous venovenous hemofiltration with dialysis removes cytokines from the circulation of septic patients.Crit Care Med1993; 21: 522–6.
172.
BraunN., GiolaiM., RosenfeldS.. Clearance of interleukin 6 during continuous veno-venous hemofiltration in patients with septic shock. A prospective controlled study.J Am Soc Nephrol1993; 4: 336 (abstract).
173.
HoffmanJ.N., FaistE., DeppischR., InthornD.. Hemofiltration in human sepsis: elimination of immuno modulartory factors.Intensive Care Med1994; 20(suppl. 2): S12 (Abstract).
174.
DinarelloC.A.. Cytokines and biocompatibility.Blood Purif1990; 8: 208–13.
175.
ArnoutM.A., HakimR.M., ToddR.F., DanaN., ColtenH.R.. Increased expression of an adhesion promoting glycoprotein in the granulocytopenia of hemodiaysis.N Engl J Med1985; 312: 457–62.
176.
HimmelfarbJ., LazarusM., HakimR.. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis.Am J Kidney Dis1991; 3: 271–6.
177.
LugerA., KovarikJ., StummvollH.K., UrbanskaA., LugerT.. Blood membrane interaction in hemodialys leads to increased cytokine production.Kidney Int1987; 32: 84–8.
178.
StrasserT., SchifflH.. Generation of leukoriene B 4 by hemodialyser membranes: a novel index of biocompatibility.Klin Wochen Schr1991; 69: 808–12.
GotloibL., BarzilayE., ShustakA., WaisZ., JaichenkoJ., LevA.. Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung.Resuscitation1986; 13: 123–32.
181.
OssenkoppeleG.J., van der MeulenJ., BronsveldW., ThijsL.G.. Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shock.Crti Care Med1985; 13: 102–4.
182.
GomezA., WangR., UnruhH.. Hemofiltration versus left ventricular dysfunction during sepsis in dogs.Anesthesiology1990; 73: 671–85.
183.
GrootendorstA.F., van BommelE.F.H., van der HovenB., van LeengoedLAMG, van OstaA.L.M.. High volume hemofiltration improves right ventricular function in endotoxin induced shock in the pig.Intensive Care Med1992; 18: 235–40.
184.
GrootendorstA.F., van BommelE.F.H., van LeengoedLAMG, van ZantenA.R.H., HuipenH.J.C., GroeneveldA.B.J.. Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs.J Crit Care1993; 8: 161–9.
185.
CoraimF., TrubelW., EbermannR., WolnerE.. Elimination of myocardial depressant substances by hemofiltration in patients with cardiogenic shock.Circ Shock1991; 34: 117 (abstract).
186.
SteinerB., PfenningerE., GruenertA., SchmitzJ.E., DellerA., KocherF.. The consequences of continuous hemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model.Intensive Care Med1991; 17: 293–8.
187.
LeeP., MatsonJ.R., PryorR.W., HinshawL.B.H.. Continuous arteriovenous hemofiltration therapy for staphylococcus aureus-induced septicemia in immature swine.Crit Care Med1993; 21: 914–24.
188.
BarzilayE., KesslerD., BerlotG., GulloA., GeberD., Ben ZeevI.. Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients.Crit Care Med1993; 17: 634–7.
189.
HarrisD.. Acute renal replacement - which treatment is best.Aust NZ J Med1990; 20: 197–200.
190.
FirthJ.D.. Renal replacement therapy on the intensive care unit.Q J Med1993; 86: 75–7.